Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion type Assertion NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_head.
- NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion description "[MMP-2 may be a useful target for breast cancer therapy when refinement of MMP inhibitors provides for MMP-specific agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_provenance.
- NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion evidence source_evidence_literature NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_provenance.
- NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion SIO_000772 14744781 NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_provenance.
- NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion wasDerivedFrom befree-2016 NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_provenance.
- NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_assertion wasGeneratedBy ECO_0000203 NP429616.RAai0D1G9LVfPr0vVRXNV1dx3iIrADnnyz5neRvG65vGc130_provenance.